Pharmx Technologies grows September quarter revenue 9%

• Pharmx Technologies recorded a 9% year-on-year revenue increase for its first quarter of FY27.
• Following the announcement, the Pharmx Technologies share price was down at $0.085.
• Growth was driven by strong adoption in its volume-based fees and Marketplace performance.

Pharmx Technologies (ASX:PHX) posted a 9% increase in first-quarter revenue compared to the prior corresponding period.

The quarterly revenue growth was boosted by volume-based fees, which accounted for 24% of recurring revenue compared to 20% in FY26.

“Revenue is up 9% on the prior corresponding period, and nearly a quarter of our recurring revenue is now volume-based, so more of our income grows with activity on the platform,” stated PharmX CEO Tom Culver.

The company stated that its Marketplace platform processed approximately 10,000 orders since going live and reached $6.9 million in gross transaction value during September, tracking ahead of its $100 million annualised run-rate target.

Following the announcement, the Pharmx Technologies share price was down at $0.085.

The business operates digital infrastructure connecting over 99% of Australian and New Zealand pharmacies across 7,000 stores.

Its core platform processes roughly $26 billion in network volume annually across Gateway EDI, Relay EDI, and its Marketplace.